SCHLAGWORTE: Aatec
‘We aim to set new standards in respiratory medicine with ATL-105’
AATec develops new therapeutics for inflammatory lung diseases based on a new recombinant version of alpha-1 antitrypsin. Backed by a pre-series A funding round...
Now online: Impact Life Sciences 04/2025!
In the newest Impact Life Sciences Special, we explore current technology trends – this time with a focus on medical technology. Industry experts provide...